UPDATE 1-Teva to sell up to seven-tranche US dollar bond Monday

July 18, 2016 12:30 PM

12 0

NEW YORK, July 18 (IFR) - Teva Pharmaceutical is selling an up to seven-tranche US dollar bond Monday to help finance its acquisition of Allergan Generics, one of the banks managing the deal told IFR.

Initial price thoughts for Teva Pharmaceutical, rated Baa2/BBB, are T+115bp area for the two-year, T+125bp area for the three-year fixed and Libor equivalent for the three-year floater, T+150bp area for the five-year, T+175bp area for the seven-year, T+190bp area for the 10-year and T+220bp area for...

Also read: ECB relaxes rule of bond lending to avoid repo squeeze

Read more

To category page

Loading...